Assumptions for disparities in case-fatality rates of coronavirus disease (COVID-19) across the globe.
Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Communicable Disease Control
/ methods
Coronavirus Infections
/ diagnosis
Delivery of Health Care
Demography
France
/ epidemiology
Germany
/ epidemiology
Health Status Disparities
Healthcare Disparities
Humans
Italy
/ epidemiology
Pandemics
Pneumonia, Viral
/ mortality
Risk Factors
SARS-CoV-2
Spain
/ epidemiology
United States
/ epidemiology
Journal
European review for medical and pharmacological sciences
ISSN: 2284-0729
Titre abrégé: Eur Rev Med Pharmacol Sci
Pays: Italy
ID NLM: 9717360
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
entrez:
21
5
2020
pubmed:
21
5
2020
medline:
28
5
2020
Statut:
ppublish
Résumé
In a short span, Coronavirus disease (COVID-19) has become the world pandemic by rapidly spreading almost to all the countries around the globe, irrespective of the continent, population size, economic status and healthcare system. Despite the number of cases increasing exponentially in most of the countries, there exist certain disparities in terms of case-fatality rates. As of April 24, 2020, the case-fatality rate of COVID-19 is about 7.0%, with 193,671 deaths and 2,761,121 confirmed cases around the world. Although the United States of America (USA), Spain, Italy, France, and Germany are the top-most affected counties in terms of confirmed cases; France, Italy and Spain are leading the list in terms of case-fatality rates. Therefore, through this mini-review, authors sought to brief on possible assumptions (five D's) that might contribute to the varying case-fatality rates among different countries across the globe.
Identifiants
pubmed: 32432785
doi: 10.26355/eurrev_202005_21215
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM